1. Home
  2. WST vs HBAN Comparison

WST vs HBAN Comparison

Compare WST & HBAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WST
  • HBAN
  • Stock Information
  • Founded
  • WST 1923
  • HBAN 1866
  • Country
  • WST United States
  • HBAN United States
  • Employees
  • WST N/A
  • HBAN N/A
  • Industry
  • WST Medical/Dental Instruments
  • HBAN Major Banks
  • Sector
  • WST Health Care
  • HBAN Finance
  • Exchange
  • WST Nasdaq
  • HBAN Nasdaq
  • Market Cap
  • WST 15.6B
  • HBAN 23.7B
  • IPO Year
  • WST N/A
  • HBAN N/A
  • Fundamental
  • Price
  • WST $222.00
  • HBAN $17.54
  • Analyst Decision
  • WST Buy
  • HBAN Buy
  • Analyst Count
  • WST 7
  • HBAN 20
  • Target Price
  • WST $331.67
  • HBAN $18.16
  • AVG Volume (30 Days)
  • WST 696.4K
  • HBAN 30.5M
  • Earning Date
  • WST 07-24-2025
  • HBAN 07-18-2025
  • Dividend Yield
  • WST 0.38%
  • HBAN 3.53%
  • EPS Growth
  • WST N/A
  • HBAN 17.13
  • EPS
  • WST 6.37
  • HBAN 1.30
  • Revenue
  • WST $2,895,800,000.00
  • HBAN $7,104,000,000.00
  • Revenue This Year
  • WST $3.38
  • HBAN $16.99
  • Revenue Next Year
  • WST $5.85
  • HBAN $5.02
  • P/E Ratio
  • WST $34.87
  • HBAN $13.49
  • Revenue Growth
  • WST N/A
  • HBAN 5.17
  • 52 Week Low
  • WST $187.43
  • HBAN $11.92
  • 52 Week High
  • WST $352.33
  • HBAN $18.45
  • Technical
  • Relative Strength Index (RSI)
  • WST 55.47
  • HBAN 74.95
  • Support Level
  • WST $215.67
  • HBAN $16.12
  • Resistance Level
  • WST $226.80
  • HBAN $16.44
  • Average True Range (ATR)
  • WST 5.26
  • HBAN 0.29
  • MACD
  • WST -0.05
  • HBAN 0.14
  • Stochastic Oscillator
  • WST 65.84
  • HBAN 92.49

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

About HBAN Huntington Bancshares Incorporated

Huntington is a regional US bank with around $200 billion in assets (as of 2024) and has a large presence, particularly in the Midwestern market. It offers a full suite of consumer deposit and lending services, along with commercial services focused on payments, investment management, capital markets, equipment financing, treasury management, and other common banking services.

Share on Social Networks: